Coya Therapeutics
COYA
58 hedge funds and large institutions have $46M invested in Coya Therapeutics in 2025 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 7 closing their positions.
375% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 4
314% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 7
70% more capital invested
Capital invested by funds: $27.1M → $46M (+$18.9M)
61% more funds holding
Funds holding: 36 → 58 (+22)
9.51% more ownership
Funds ownership: 28.44% → 37.94% (+9.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.86M |
| 2 |
AIC
AWM Investment Company
New York
|
+$4.41M |
| 3 |
DCM
DME Capital Management
New York
|
+$2.31M |
| 4 |
PMG
Private Management Group
Irvine,
California
|
+$1.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$872K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$792K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$275K |
| 4 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
-$136K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$114K |
COYA Hedge Fund Activity: Q4 2025 in Review
58 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q4 2025, worth a combined $46M — up 70% from $27.1M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new COYA positions and 7 closed out — a net gain of 22 holders — while 19 added to existing stakes and 4 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $4.86M. The largest seller was Dauntless Investment Group, exiting entirely with an estimated $872K sold.
- 58 institutional investors held Coya Therapeutics (COYA) as of Q4 2025, up from 36 in Q3 2025.
- Funds reported $46M of Coya Therapeutics stock for Q4 2025, up 70% quarter-over-quarter.
- 29 funds opened new Coya Therapeutics positions in Q4 2025 and 7 closed out, a net change of +22 holders.
- The largest Coya Therapeutics buyer in Q4 2025 was Alyeska Investment Group, an estimated $4.86M added.
- The largest Coya Therapeutics seller in Q4 2025 was Dauntless Investment Group, an estimated $872K sold.
Based on aggregated 13F filings for Q4 2025.